Richard Giroux Sells 24,000 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) Stock

MeiraGTx Holdings plc (NASDAQ:MGTX) CFO Richard Giroux sold 24,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $6.29, for a total value of $150,960.00. Following the completion of the sale, the chief financial officer now owns 849,947 shares of the company’s stock, valued at $5,346,166.63. This trade represents a 2.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

MeiraGTx Stock Performance

Shares of MeiraGTx stock opened at $6.41 on Wednesday. The business’s fifty day simple moving average is $6.21 and its 200-day simple moving average is $5.25. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.86. The firm has a market cap of $500.96 million, a PE ratio of -5.30, a price-to-earnings-growth ratio of 0.34 and a beta of 1.26. MeiraGTx Holdings plc has a 52 week low of $3.85 and a 52 week high of $7.37.

Analyst Ratings Changes

Several research analysts have recently weighed in on MGTX shares. Royal Bank of Canada boosted their price target on shares of MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research report on Thursday, November 14th. Chardan Capital restated a “buy” rating and set a $36.00 price target on shares of MeiraGTx in a report on Monday, November 18th.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of MGTX. SG Americas Securities LLC grew its holdings in shares of MeiraGTx by 13.3% in the fourth quarter. SG Americas Securities LLC now owns 22,240 shares of the company’s stock valued at $135,000 after purchasing an additional 2,617 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in MeiraGTx by 19.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company’s stock valued at $75,000 after buying an additional 2,839 shares during the period. JPMorgan Chase & Co. grew its stake in shares of MeiraGTx by 1.2% in the third quarter. JPMorgan Chase & Co. now owns 342,667 shares of the company’s stock worth $1,429,000 after acquiring an additional 4,186 shares in the last quarter. Rhumbline Advisers grew its stake in shares of MeiraGTx by 10.8% in the second quarter. Rhumbline Advisers now owns 52,996 shares of the company’s stock worth $223,000 after acquiring an additional 5,178 shares in the last quarter. Finally, State Street Corp increased its position in shares of MeiraGTx by 0.9% during the third quarter. State Street Corp now owns 574,727 shares of the company’s stock worth $2,397,000 after acquiring an additional 5,251 shares during the period. Institutional investors and hedge funds own 67.48% of the company’s stock.

MeiraGTx Company Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.